Monday, June 18, 2007

Bioenvision shareholder urges board to reduce Soros' influence

(Reuters) - Rouhandeh, chairman of SCO Capital Partners LLC, owns about
13.4 percent stake in the company.




According to the filing, two board members are employed by
Perseus-Soros/Aisling and two others work for companies in
which the Soros fund has or has had an investment. This
represents 67 percent of the board, while Perseus-Soros/Aisling
owns only 12 percent of the company, the letter said.


Read more at Reuters.com Mergers News

No comments: